Inmagene Biopharmaceuticals
Biotechnology ResearchView the employees at
Inmagene Biopharmaceuticals-
Yang Zhan, Ph.D. Inmagene Biopharmaceuticals - Senior Program Manager
-
Shanghai, China
-
Rising Star
Cailin Fredrickson, MPH Executive Assistant @ Inmagene Biopharmaceuticals-
San Diego, California, United States
-
Top 10%
Carina Freedman, MS Sr. Clinical Study Manager-
Rising Star
Dan Ding Hua Medicine - Regulatory Affairs-
Shanghai, China
-
Top 10%
Francis(Pengcheng) F. Senior VP of Non-clinical Development-
Hangzhou, Zhejiang, China
-
Top 10%
Overview
Diseases do not recognize borders; why should drug innovation? We are a team of scientists and physicians driven by a shared commitment: to fulfill unmet medical needs for patients worldwide by harnessing the most effective resources and efficient processes for drug development. We may take the brainchild of a scientist in one country to conduct proof of concept studies in another, and seamlessly transition to later clinical development globally. We coined our approach “Borderless Innovation.” Focused on immunology and inflammation, we are developing a new generation of drug candidates characterized by prolonged pharmacokinetic and pharmacodynamic effects as well as improved safety margins. This will potentially enable improved efficacy/safety profiles and dosing convenience. Leveraging cutting-edge technology, we have a rich pipeline consisting of four clinical-stage assets, targeting validated pathways, and multiple innovative preclinical candidates.
-